Trexquant Investment’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,329
Closed -$1.21M 1819
2022
Q3
$1.21M Buy
17,329
+11,916
+220% +$832K 0.04% 476
2022
Q2
$363K Sell
5,413
-20,711
-79% -$1.39M 0.02% 1018
2022
Q1
$2.15M Buy
26,124
+23,435
+872% +$1.93M 0.1% 250
2021
Q4
$394K Buy
+2,689
New +$394K 0.02% 777
2021
Q3
Sell
-4,850
Closed -$783K 1582
2021
Q2
$783K Buy
+4,850
New +$783K 0.07% 365
2021
Q1
Sell
-9,742
Closed -$2.14M 1552
2020
Q4
$2.14M Buy
+9,742
New +$2.14M 0.23% 115
2019
Q4
Sell
-8,665
Closed -$675K 1321
2019
Q3
$675K Buy
8,665
+5,005
+137% +$390K 0.06% 374
2019
Q2
$377K Buy
+3,660
New +$377K 0.03% 541
2019
Q1
Sell
-6,964
Closed -$295K 1393
2018
Q4
$295K Buy
+6,964
New +$295K 0.02% 787
2018
Q2
Sell
-26,650
Closed -$818K 1307
2018
Q1
$818K Buy
+26,650
New +$818K 0.06% 473
2017
Q2
Sell
-42,879
Closed -$223K 1260
2017
Q1
$223K Buy
42,879
+16,447
+62% +$85.5K 0.03% 912
2016
Q4
$126K Buy
26,432
+4,599
+21% +$21.9K 0.02% 894
2016
Q3
$144K Sell
21,833
-26,345
-55% -$174K 0.03% 672
2016
Q2
$263K Buy
+48,178
New +$263K 0.03% 708
2016
Q1
Sell
-29,900
Closed -$945K 1232
2015
Q4
$945K Sell
29,900
-6,200
-17% -$196K 0.08% 414
2015
Q3
$1.24M Buy
+36,100
New +$1.24M 0.11% 331